241 results on '"Lui, Grace Chung‐Yan"'
Search Results
2. Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life
3. Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
4. Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
5. User Engagement on a Novel Educational Health Intervention Aimed at Increasing HPV Vaccine Uptake in Hong Kong: a Qualitative Study
6. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome
7. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
8. Case series of HIV SARS-CoV-2 co-infection in Chinese adults
9. EFFECTS OF A SCHOOL-BASED MULTIDISCIPLINARY HPV PREVENTION PROGRAMME FOR ADOLESCENT GIRLS AND PARENTS
10. A Machine Learning–Based Risk Score for Prediction of Infective Endocarditis Among Patients With Staphylococcus aureus Bacteremia—The SABIER Score
11. Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
12. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure
13. Letter: Rethinking the lower incidence of HCC in HIV‐infected patients—A closer look at confounding factors. Authors' reply
14. Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E : A Territorywide Cohort Study From 2000 to 2016
15. Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients
16. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
17. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B
18. Dynamicity of HIV Pre-exposure Prophylaxis Usage Pattern and Association with Executed Adherence in MSM: An Implementation Study in Hong Kong
19. Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019
20. Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections
21. On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis
22. Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4 + T Cells
23. Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes
24. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
25. Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia.
26. Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: A cluster randomized controlled trial
27. Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis
28. Epidemiology and Outcomes of Hypernatraemia in Patients with COVID-19—A Territory-Wide Study in Hong Kong
29. Epidemiology and outcomes of hyponatremia in patients with COVID-19—A territory-wide study in Hong Kong
30. Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
31. Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients
32. Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)
33. The differential impacts of early detection and accelerated antiretroviral therapy on the epidemiologic trend of sexually acquired HIV infection in Hong Kong
34. User Engagement on a Novel Educational Health Intervention Aimed at Increasing HPV Vaccine Uptake in Hong Kong: a Qualitative Study.
35. Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine
36. Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19).
37. Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis.
38. Use of Proton-Pump Inhibitor Is Not Associated with Adverse Clinical Outcomes in COVID-19 Patients: A Territory-Wide Cohort Study
39. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
40. Dysnatraemia During COVID-19 Diagnosis and Background Hyponatraemia Are Associated With Adverse Clinical Outcomes of COVID-19
41. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong
42. Managing cardiovascular risk in people living with HIV in Asia – where are we now?
43. Transmitted drug resistance profile of men who have sex with men newly diagnosed with HIV in Hong Kong
44. Comparison between daily and on‐demand PrEP (pre‐exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open‐label, crossover trial
45. IDDF2021-ABS-0122 No association between proton-pump inhibitor use and adverse clinical outcomes of COVID-19: a territory-wide cohort study of 8,675 patients
46. Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
47. Sodium‐glucose co‐transporter 2 inhibitors reduce hepatic events in diabetic patients with chronic hepatitis B
48. Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19
49. SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19
50. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.